Updated:
Cedars-Sinai Medical Center (Defined Contribution)
Cedars-Sinai Medical Center established its defined contribution plan to manage employee retirement savings. Pasy Wang serves as chief investment officer with...
Cedars-Sinai Medical Center (Defined Contribution)
Cedars-Sinai Medical Center established its defined contribution plan to manage employee retirement savings. Pasy Wang serves as chief investment officer with responsibility for the plan alongside other hospital investment pools. No public founding date for the plan itself appears in available records. The plan allocates across short-term investment funds and core options that include mutual funds and collective investment trusts. Confirmed positions include holdings in healthcare companies such as Capricor Therapeutics and Prometheus Biosciences. Geographic exposure centers on the United States with additional venture commitments through Cedars-Sinai Health Ventures. The investment office maintains an administrative location at 6500 Wilshire Blvd in Los Angeles. Pasy Wang participates in industry events including the Endowments & Foundations Roundtable. Brian Chen supports investment management as managing director. The plan sits inside the larger 501(c)(3) hospital structure, which also maintains a fine art collection and multiple real estate holdings including the main campus and Marina Del Rey Hospital project.
General information
Firm type
Pension Fund
Year founded
1974
Location
Region
North America
Country
United States
City
Los Angeles
Principals
Pasy Wang
Chief Investment Officer
Brian Chen
Managing Director, Investments
Sector focus
Frequently asked questions
Who runs investment decisions at Cedars-Sinai Medical Center (Defined Contribution)?
Pasy Wang serves as chief investment officer and oversees the plan. Brian Chen acts as managing director of investments.
What liquidity terms apply to the plan?
Most core investment options offer daily liquidity through mutual funds and collective investment trusts.
Does the plan hold public equity positions?
Yes. Reported holdings include a 10 percent stake in Capricor Therapeutics and a position in Prometheus Biosciences.
How does the plan relate to Cedars-Sinai Health Ventures?
The plan participates in venture investments through Cedars-Sinai Health Ventures in companies such as Vista.ai and Regard.
What is the plan's primary geographic focus?
Investments center on the United States with some exposure to Canadian companies such as Paperplane Therapeutics.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on pension funds?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: